Go offline with the Player FM app!
Episode 44: Structure Forward: Using Structural Biology Pipelines to Achieve Favorable Antibody Responses
Manage episode 352120998 series 2967424
Over the last two decades, cryogenic electron microscopy (cryo-EM) has transformed from what Dr. Andrew Ward calls the “outcast of structural biology” to one of the most promising technologies in the field. Ward, professor of integrative structural and computational biology at Scripps Research Institute, speaks with moderator Brandon DeKosky, assistant professor of chemical engineering at the Massachusetts Institute of Technology, about the evolution of cryo-EM and how its direct detector transformative technology enables scientists to craft favorable antibody responses.
Ward also talks about cryo-EM’s technological advantages when working with proteins, sterilizing immunity, and designing accurate structural biology pipelines that lead to next-generation vaccines. Finally, Ward offers his predictions about the immunological breakthroughs he thinks structural biologists will accomplish in the very near future.
Links from this episode:
Scripps Research Institute
PepTalk Conference
Discovery on Target Conference
75 episodes
Manage episode 352120998 series 2967424
Over the last two decades, cryogenic electron microscopy (cryo-EM) has transformed from what Dr. Andrew Ward calls the “outcast of structural biology” to one of the most promising technologies in the field. Ward, professor of integrative structural and computational biology at Scripps Research Institute, speaks with moderator Brandon DeKosky, assistant professor of chemical engineering at the Massachusetts Institute of Technology, about the evolution of cryo-EM and how its direct detector transformative technology enables scientists to craft favorable antibody responses.
Ward also talks about cryo-EM’s technological advantages when working with proteins, sterilizing immunity, and designing accurate structural biology pipelines that lead to next-generation vaccines. Finally, Ward offers his predictions about the immunological breakthroughs he thinks structural biologists will accomplish in the very near future.
Links from this episode:
Scripps Research Institute
PepTalk Conference
Discovery on Target Conference
75 episodes
All episodes
×
1 Episode: 72 - Pamela Barney on HR Lessons to Meet the Needs of Biotech 35:23

1 PEGS Young Scientist Keynote Jessica Stark on the Role of Glycans in Cancer Research 28:38

1 Episode: 70 - Views on Machine Learning and AI in the Antibody and Protein Engineering Space 49:36

1 Episode: 69 - Conversation with Sir Greg Winter on the 50th Anniversary of the Milstein and Köhler Paper 50:36

1 Episode: 68 - Changing the Game of Protein-Protein Interactions With Randolph Lopez 46:00

1 Episode: 67 - Anthony Tolcher Discusses Oncology, Dual-Payload Technology, and the ADC Field 42:34

1 Episode: 66 - John Lambert on Antibody Drug Conjugates Then, Now, & Beyond 39:43

1 Episode 65- Tariq Ghayur on the Renaissance of Bispecifics and ADCs, AI, and More 31:55

1 Episode: 64 - Peyton Greenside on AI’s Role in Antibody Engineering, Optimization, and More 32:31

1 Episode: 63 - Discussing Protein Signaling and Structural Biology With Andrew Kruse 38:18

1 Episode: 62 - AI/ML in Antibody Discovery and Engineering: Reality, Hope, Future, and Hype 1:03:57

1 Episode: 61 - Tomoyuki Igawa Discusses Leadership and His Experiences in Discovery and Development 55:04

1 Episode: 60 - Lesley Millar-Nicholson on Technology Licensing, Navigating Patents, and Building Teams 48:14

1 Episode: 59 - Gabriel Rocklin on Protein Biophysics and Protein Design 33:10

1 Episode: 58 - Janine Schuurman Reflects on the Key Lessons and Accomplishments of Her 20-Year Career 55:05
Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.